News & Trending Insurance News

Will Medicare Cover Ozempic or Wegovy in 2026? What Retirees Need to Know About GLP-1 Coverage

Changes could be coming to GLP-1 coverage for weight loss.

By Kristin Hitchcock , Edited by Laura Hohenstein

Updated May 1, 2026

Add Us On Google

There's a quiet frustration building among retirees right now, and it ties directly into how overlooked senior benefits often work in practice. You've probably seen the headlines about drugs like Ozempic and Wegovy helping people lose significant weight and improve their health.

But if you're on Medicare, the reality has been pretty simple: unless you have a qualifying condition, you're likely paying out of pocket or not getting access at all.

That may start to change in 2026. Medicare isn't fully opening the door, but it is cracking it. A temporary program could give some retirees a path to coverage, at least for a limited time. Here's how it actually works.

Get a protection plan on all your appliances

Did you know if your air conditioner stops working, your homeowner’s insurance won’t cover it? Same with plumbing, electrical issues, appliances, and more.

A home warranty from Choice Home Warranty could pick up the slack where insurance falls short.

For a limited time, you can get your first month free with a Single Payment home warranty plan.

Get a free quote

Why Medicare has not covered GLP-1 drugs for weight loss

This isn't a simple policy choice. Medicare has been restricted by law from covering medications strictly for weight loss. That's why even as these drugs become more common, coverage didn't follow.

Right now, GLP-1 drugs are typically only covered when they're tied to specific medical conditions, like:

Ozempic and Mounjaro for Type 2 diabetes
Wegovy for certain patients with cardiovascular risk
Zepbound for obstructive sleep apnea

If your goal is weight loss alone, Medicare has usually said no. That's been the sticking point.

Who really has the cheapest auto insurance in your area? Check your zip code here.

What's changing in July 2026: the Medicare GLP-1 Bridge

This is where things get interesting. Starting in July 2026, the Centers for Medicare & Medicaid Services is expected to roll out a temporary program called the "Medicare GLP-1 Bridge."

Think of it as a trial run. Under this program, some retirees may be able to get coverage for drugs like Weygovy and Zepbound even when weight loss is the main goal.

So far, we know that you'll need Part D or a Medicare Advantage plan with drug coverage. Copays could land around $50 per month for those who qualify, and your doctor will need to submit prior authorization.

It's not automatic, and it's not guaranteed. But it's a real shift from where things stand today.

Who might actually qualify

This won't be a free-for-all, though. Many people may be surprised when they don't actually qualify for coverage.

Eligibility depends on several factors, and the specifics might change between now and July. In many cases, you'll need some sort of documentation of obesity and related health issues, as well as a provider who is willing to go through the approval process. Not all plans may participate in this trial period, either.

Two retirees could have two very different approval experiences. One may get approved right away, and the other might run into roadblocks. Right now, we don't really know what that will look like in practice.

If you’re over 50, take advantage of massive discounts and financial resources

Over 50? Join AARP today— because if you’re not a member you could be missing out on huge perks. When you start your membership today, you can get discounts on things like travel, meal deliveries, eyeglasses, prescriptions that aren’t covered by insurance and more.

Start your membership by creating an account here and filling in all of the information (Do not skip this step!) Doing so will allow you to take up 25% off your AARP membership, making it just $15 the first year with auto-renewal.

Why this program only lasts through 2027

The GLP-1 Bridge is scheduled to end at the close of 2027. The goal isn't just to expand access. Medicare is just trying to answer some big questions, like how much the drug will cost at scale and whether they actually improve long-term health outcomes.

It might help them approve the drug permanently in the future, but, for now, that isn't the goal.

For retirees, that means this window could be short. Waiting too long to apply for coverage might limit how many months you can use the medication.

What comes after: the 2027 BALANCE model

In 2027, Medicare plans to shift into something more permanent called the BALANCE model. However, coverage may depend on the plan you choose. Not every Part D or Medicare Advantage plan is expected to participate.

That's an important difference from the drug just being "approved" across the board. Coverage may technically exist, but it might not exist for you, specifically.

Why your plan choice will matter more than usual

This is where you can start having some control over the process. During Open Enrollment, the details of your plan could directly impact whether you can access these medications.

If you're interested in these medications, you should check each plan's formulary to see if they're covered. Check for prior authorization requirements and whether step therapy rules apply.

This is one of those situations where reading the fine print is actually important, more so than just reading the headline. It's not just about whether Medicare covers something. It's about whether your specific plan does.

Retirement News: Almost 80% of Americans fear a retirement age increase — here’s the real reason why

The bigger picture for retirees

It's easy to look at this and think, "Finally, Medicare is covering weight loss drugs." The truth is a little more measured. Access is expanding, but slowly and not for everyone. There will be several hoops to jump through, and for many retirees, the process might be quite complicated.

Still, this is a meaningful shift from the last few years. Just a year ago, there was essentially no path to coverage for weight loss alone. Now, there's at least a starting point.

Bottom line

Medicare is starting to slowly move on GLP-1 coverage, but only in a limited way. In 2026, some retirees may start to gain access to drugs like Wegovy and Zepbound through a short-term program, though approval isn't guaranteed and depends on your doctor and health profile.

The bigger shift might come in 2027, when coverage may expand but will depend largely on the plan you choose. It's essential to check your plan options carefully if you're considering these medications.

It may also be worth talking to your doctor before Open Enrollment so you can understand what documentation or authorizations may be required. That way, you can compare plans with real information in hand and make the right moves instead of scrambling after you've already locked in coverage for the year.

More from FinanceBuzz: